Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Cellectar Biosciences, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-13.05%
EBIT to Interest (avg)
-28.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.43
Sales to Capital Employed (avg)
0
Tax Ratio
0.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
33.43%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.15
EV to EBIT
0.07
EV to EBITDA
0.07
EV to Capital Employed
0.52
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
723.40%
ROE (Latest)
-227.28%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -18.59 MM
NET PROFIT(HY)
Higher at USD -11.32 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 21.54 MM
Here's what is working for Cellectar Biosciences, Inc.
Net Profit
Higher at USD -11.32 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -18.59 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cellectar Biosciences, Inc.
Cash and Eqv
Lowest at USD 21.54 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






